Viemed Healthcare
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
16.16
Price/Sales ratio
1.14
Earnings per Share (EPS)
$0.43

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
1.137.6155.378.3114.1427.439.5322.5846.9629.3962.1314.14
Price/Sales ratio
0.461.962.161.442.202.912.281.762.101.642.782.20
Price/Book Value ratio
1.275.835.272.864.115.353.682.173.002.643.985.35
Price/Cash Flow ratio
1.417.2410.605.656.4312.258.569.1610.536.6513.936.43
Price/Free Cash Flow ratio
1.597.3514.348.478.8541.0113.6274.9360.2515.7479.718.85
Price/Earnings Growth ratio
N/A-0.08-0.640.010.62-1.850.03-0.30-1.350.36-2.08-1.85
Dividend Yield
34.88%9.51%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
83.44%77.39%60.14%73.76%74.43%69.78%61.00%62.71%60.99%61.62%60.99%69.78%
Operating Profit Margin
40.73%29.01%1.22%18.80%26.11%10.89%20.39%9.89%5.94%7.83%5.94%10.89%
Pretax Profit Margin
40.58%28.77%0.34%17.45%15.84%10.95%20.07%10.68%6.47%7.86%6.47%10.95%
Net Profit Margin
40.58%25.80%3.91%17.42%15.59%10.62%24.01%7.79%4.48%5.59%4.48%10.62%
Effective Tax Rate
N/A10.34%-1026.60%0.18%1.56%3.08%-19.59%27.00%30.78%28.82%30.78%1.56%
Return on Assets
93.14%39.83%4.97%21.69%19.01%10.32%28.01%7.73%5.31%6.61%8.04%10.32%
Return On Equity
112.10%76.61%9.53%34.43%29.04%19.50%38.59%9.62%6.40%8.99%6.54%19.50%
Return on Capital Employed
112.51%71.43%2.46%35.95%46.64%15.43%29.90%11.56%8.40%11.67%14.12%15.43%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A1.072.04N/AN/AN/A2.101.07
Quick Ratio
3.881.391.041.161.181.021.942.511.911.051.711.18
Cash ratio
0.950.370.470.380.610.511.341.590.890.390.890.61
Days of Sales Outstanding
76.4184.8755.7976.0749.4252.4534.3945.8840.5036.7940.4352.45
Days of Inventory outstanding
74.3071.2747.8448.4063.1420.4716.4620.5424.0824.0524.0824.08
Operating Cycle
150.72156.14103.63124.48112.5672.9250.8666.4264.5960.8534.0572.92
Days of Payables Outstanding
71.5641.1154.99100.37128.6870.7414.9427.0817.8638.5117.8670.74
Cash Conversion Cycle
79.16115.0248.6324.11-16.112.1835.9139.3446.7222.3328.51-16.11
Debt Ratios
Debt Ratio
0.000.080.01N/AN/A0.190.090.050.000.040.250.25
Debt Equity Ratio
0.000.160.03N/AN/A0.370.120.060.000.060.200.37
Long-term Debt to Capitalization
N/A0.03N/AN/AN/A0.140.060.04N/A0.050.000.14
Total Debt to Capitalization
0.000.140.03N/AN/A0.270.110.060.000.050.000.27
Interest Coverage Ratio
N/AN/AN/AN/AN/A29.3648.04N/AN/AN/A41.8829.36
Cash Flow to Debt Ratio
303.644.9414.00N/AN/A1.153.383.5956.056.3939.9839.98
Company Equity Multiplier
1.201.921.911.581.521.891.371.241.201.350.791.89
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.320.270.200.250.340.230.260.190.190.240.190.23
Free Cash Flow / Operating Cash Flow Ratio
0.880.980.730.660.720.290.620.120.170.420.170.29
Cash Flow Coverage Ratio
303.644.9414.00N/AN/A1.153.383.5956.056.3939.9839.98
Short Term Coverage Ratio
303.646.5214.00N/AN/A2.157.6711.5756.0542.1756.0556.05
Dividend Payout Ratio
39.71%72.50%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A